Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 80Breast 74Other hematologic neoplasm 25Thoracic 22Sarcoma 22Genitourinary 20Gynecologic 19Plasma cell 11CNS 11Gastrointestinal 7Tumor-Agnostic 6Classical hematology 6Head & Neck 4Endocrine 4Other solid neoplasm 3Dermatologic 2Other 1NET 1

Conditions

Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × pegfilgrastim × Other × Clear all
NCT00352118 2017-12-28

Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
4 enrolled 4 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡